Transgenic superoxide dismutase mice: Increased mesolimbic ?-opioid receptors results in greater opioid-induced stimulation and opioid-reinforced behavior
by
Elmer GI G, Evans JL J, Goldberg SR S, Epstein CJ C, Cadet JL J
Behavioral Pharmacology and Genetics Section,
Preclinical Pharmacology Laboratory,
National Institute on Drug Abuse,
NIH, Addiction Research Center,
Box 5180, Baltimore,
MD 21224, USA.
Behav Pharmacol 1996 Nov; (7):628-639


ABSTRACT

Consequent to the insertion of the human Cu/Zn-superoxide dismutase (SOD) transgene, SOD transgenic mice (SOD-Tg) show higher concentrations of the primary receptor thought to be involved in opioid reinforcement (mu). These increases are observed in areas specifically associated with the primary neurotransmitter thought to be involved in addiction (dopamine), and in neuroanatomical regions thought to mediate substance abuse (mesolimbic). In the present study we have tested the idea that these increases in mu-receptors are associated with parallel changes in mu-mediated behaviors. Baseline and morphine-induced locomotor activity were significantly altered in the SOD-Tg mice. A qualitative change in the nature of acute and chronic morphine-induced locomotor activity was demonstrated by a significant change in the slope of the dose-effect curve. SOD-Tg mice were significantly more sensitive to the locomotor stimulant effects of morphine. Intravenous morphine-reinforced behavior was also altered in the SOD-Tg mice. SOD-Tg mice showed significant dose-related changes in operant lever-press responding maintained by morphine injection and significantly greater amounts of behavior were maintained by the drug than by vehicle under an intermittent schedule of reinforcement. In addition, SOD-Tg mice increased operant responding for the drug when the amount of behavior required to maintain drug intake increased 10-fold under a PR schedule of reinforcement. In contrast, in wild-type mice morphine injections failed to maintain greater amounts of behavior than vehicle, there were no dose-related changes in behavior, and when response requirements increased under the PR schedule, morphine intake decreased significantly. Thus, SOD transgene insertion significantly enhanced the efficacy of morphine as a reinforcer.
Mu
Pain
Heroin
Tolerance
Methadone
Receptor subtypes
Morphine/verapamil
Fentanyl and ketamine
Dynorphin and dopamine
Mu opioid receptor subtypes
Genes, pharmacology and mu
Depression, opioids and the HPA
Kappa upregulation and addiction
Opioids, goldfish and the giant toad
Mice without mu don't miss their moms
Mu-opioid receptors, drugs and reward
Opioids, depression and learned helplessness


Refs
and further reading

HOME
HedWeb
Nootropics
Cocaine.org
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family